A. Riva
Impact in
- Oncology top 1%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Neutropenia and Cancer Infections
- Colorectal Cancer Treatments and Studies
- Cancer Research top 2%
- Breast Cancer Treatment Studies
Papers in
- Oncology 38
- Cancer Treatment and Pharmacology 30
- HER2/EGFR in Cancer Research 16
- Neutropenia and Cancer Infections 8
- Colorectal Cancer Treatments and Studies 3
-
- Breast Cancer Treatment Studies 12
- Co-authors
- N. Azli (10 shared papers)P. Fumoleau (7 shared papers)Jean‐Marc Nabholtz (3 shared papers)Miguel Martín (4 shared papers)Tadeusz Pieńkowski (4 shared papers)Guido Sauter (4 shared papers)Michael F. Press (4 shared papers)Mark A. Lindsay (6 shared papers)
- Journals
- Journal of Clinical Oncology (11 papers)European Journal of Cancer (6 papers)Annals of Oncology (5 papers)British Journal of Cancer (3 papers)Clinical Breast Cancer (3 papers)
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
A. Riva
45 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 97
- Oncology 1.9k
- Cancer Research 764
- Dermatology 242
- Radiology, Nuclear Medicine and Imaging 300
- Pulmonary and Respiratory Medicine 353
Countries citing papers authored by A. Riva
This map shows the geographic impact of A. Riva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Riva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Riva more than expected).
Fields of papers citing papers by A. Riva
This network shows the impact of papers produced by A. Riva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Riva. The network helps show where A. Riva may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Riva, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 348 | |
| 2 | 2003 | 290 | |
| 3 | 2005 | 232 | |
| 4 | 2010 | 166 | |
| 5 | 2010 | 146 | |
| 6 | 2011 | 108 | |
| 7 | 1999 | 106 | |
| 8 | 2001 | 91 | |
| 9 | 1996 | 88 | |
| 10 | 1996 | 74 | |
| 11 | 2001 | 47 | |
| 12 | Taxoids in combination with anthracyclines and other agents: pharmacokinetic considerations. | 1998 | 41 |
| 13 | 2004 | 40 | |
| 14 | 1999 | 39 | |
| 15 | 2002 | 37 | |
| 16 | 2000 | 36 | |
| 17 | 2002 | 35 | |
| 18 | Docetaxel vs mitomycin plus vinblastine in anthracycline-resistant metastatic breast cancer. | 1997 | 31 |
| 19 | 1992 | 29 | |
| 20 | 1997 | 27 |
About A. Riva
A. Riva is a scholar working on Oncology, Cancer Research, Dermatology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine, having authored 46 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (30 papers), HER2/EGFR in Cancer Research (16 papers), Breast Cancer Treatment Studies (12 papers), Chemotherapy-related skin toxicity (10 papers), Neutropenia and Cancer Infections (8 papers), Chemotherapy-induced cardiotoxicity and mitigation (7 papers), Lung Cancer Treatments and Mutations (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). The work is most often cited by research in Oncology (1.9k citations), Cancer Research (764 citations), Dermatology (242 citations), Radiology, Nuclear Medicine and Imaging (300 citations) and Pulmonary and Respiratory Medicine (353 citations). A. Riva has collaborated with scholars based in Italy, United States and France. Frequent co-authors include N. Azli, P. Fumoleau, Jean‐Marc Nabholtz, Miguel Martín, Tadeusz Pieńkowski, Guido Sauter, Michael F. Press, Mark A. Lindsay, B Chevallier and Dennis J. Slamon. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology, British Journal of Cancer and Clinical Breast Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.